The FDA has granted Teleflex clearance for new versions of its Arrow GPSCath Balloon Dilatation Catheter that have 80-centimeter lengths and higher burst-pressure ratings. The device, which was acquired by Teleflex through its acquisition of Hotspur Technologies last year, is used to treat patients with peripheral artery disease.
Teleflex wins expanded FDA clearance for PAD device
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Director, Corporate Counsel - Regulatory Law||
|Vice President of Finance||
Urban Health Plan, Inc.
|Active Implantable Medical Device (AIMD) Product Expert||
Blue Cross Blue Shield of Louisiana
|Baton Rouge, LA|